Cardiac-specific troponin-I (cTnI) in a post-mortem setting
Open Access
- 23 May 2025
- journal article
- research article
- Published by Springer Nature in International journal of legal medicine
- Vol. 139 (5) , 1-10
Abstract
Cardiac-specific troponin (cTn) is widely used in clinical medicine to support a diagnosis of acute myocardial infarction. Several studies have explored the value of cTn testing in deceased individuals. These studies suggest that -although there are important limitations associated with its use- post-mortem cTn can be useful in selected cases. A decision for post-mortem cTn testing should however be influenced by factors that have not been explored in much detail. This includes the success rate of post-mortem cTn testing, and whether cTn levels are stable after death. Therefore, this study addresses the post-mortem availability and stability of cardiac-specific Troponin I (cTnI). Post-mortem availability was determined by analysing the success rate in 250 high-sensitivity (hs-)cTnI tests on post-mortem blood samples, and its relationship with variables such as sample location, sample type, post-mortem interval, and decomposition. Post-mortem stability was explored by comparing post-mortem cTnI levels between two samples from the same individual, taken at different times. Post-mortem hs-cTnI tests were successful in 86.4% of cases (216/250), with little effect of sex, age, or cardiopulmonary resuscitation. Visible decomposition precluded a successful test. Other variables associated with decomposition (such as increased post-mortem interval) also affected test success negatively. Our results furthermore suggest that cTnI is very unstable post-mortem, with marked differences in hs-cTnI test results between samples from the same individual. The differences were large (on average 18734 ng/L) and not unidirectional. Instability appeared to increase with larger time intervals, but the results were overall erratic and difficult to interpret. We conclude that hs-cTnI testing results are generally available in a post-mortem setting, but that testing should be performed on the earliest available blood sample. Samples from decomposed individuals should not be tested. Furthermore, the severe instability of cTnI indicates that any post-mortem hs-cTnI result must be interpreted with caution.Keywords
Funding Information
- Monash University
This publication has 29 references indexed in Scilit:
- Post-mortem in situ stability of serum markers of cerebral damage and acute phase responseInternational journal of legal medicine, 2018
- High-sensitive cardiac troponin hs-TnT levels in sudden deaths related to atherosclerotic coronary artery diseaseForensic Science International, 2018
- Cardiac troponins and NT-proBNP in the forensic setting: Overview of sampling site, postmortem interval, cardiopulmonary resuscitation, and review of the literatureForensic Science International, 2018
- Guidelines for autopsy investigation of sudden cardiac death: 2017 update from the Association for European Cardiovascular PathologyVirchows Archiv, 2017
- Cardiac troponin T determination by a highly sensitive assay in postmortem serum and pericardial fluidForensic Science, Medicine and Pathology, 2016
- Cardiac troponin T in forensic autopsy casesForensic Science International, 2013
- Postmortem cardiac troponin-I levels predict intramyocardial damage at autopsyJournal of Thrombosis and Thrombolysis, 2007
- Using Accumulated Degree-Days to Estimate the Postmortem Interval from Decomposed Human RemainsJournal of Forensic Sciences, 2005
- Biochemical analysis and immunohistochemical determination of cardiac troponin for the postmortem diagnosis of myocardial damage2005
- Diagnostic efficacy of biochemical markers in diagnosis post-mortem of ischaemic heart diseaseForensic Science International, 2004